No Data
Sinopharm Tech (08156) has appointed Peng Sheng Certified Public Accountants as its auditor.
Sinopharm Tech (08156) announced that due to various factors considered by the accounting firm KPMG, ...
Express News | Corrected-Sinopharm Tech Holdings FY23 (Not FY24) Revenue HKD 42.8 Million
Express News | Sinopharm Tech Holdings FY Revenue HKD 42.8 Million
Sinopharm Tech (08156.HK) proposes to restructure its share capital.
Sinopharm Tech (08156.HK) announced on June 14 that the board of directors has proposed to implement (i) share capital reduction, which involves canceling and paying up the share capital (limited to HKD 0.3 per share) to reduce the par value of each issued share from HKD 0.3125 to HKD 0.0125 so that the issued shares with a par value of HKD 0.0125 per share in the company's share capital will become a new share; and (ii) after the share capital reduction takes effect, the total proceeds generated from the share capital reduction will be used to offset the company's accumulated losses. Following the effectiveness of the share capital reduction, the statutory but unissued shares per share will
Express News | Sinopharm Tech - to Allot and Issue 300 Mln Integrated Asset Management (Asia) Shares at HK$0.1 per Share
Express News | Sinopharm Tech - Proposes to Implement Capital Reduction Involving Reduction of Par Value of Each Issued Share From HK$0.3125 to HK$0.0125
No Data
